JPS6126505A - Black particle - Google Patents

Black particle

Info

Publication number
JPS6126505A
JPS6126505A JP59148096A JP14809684A JPS6126505A JP S6126505 A JPS6126505 A JP S6126505A JP 59148096 A JP59148096 A JP 59148096A JP 14809684 A JP14809684 A JP 14809684A JP S6126505 A JPS6126505 A JP S6126505A
Authority
JP
Japan
Prior art keywords
particles
acrylonitrile
polymerization
black particles
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59148096A
Other languages
Japanese (ja)
Inventor
Yasuo Murao
康雄 村尾
Kumiko Miura
三浦 久美子
Shuntaro Hosaka
保坂 俊太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP59148096A priority Critical patent/JPS6126505A/en
Publication of JPS6126505A publication Critical patent/JPS6126505A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/087Binders for toner particles
    • G03G9/08702Binders for toner particles comprising macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • G03G9/08726Polymers of unsaturated acids or derivatives thereof
    • G03G9/08731Polymers of nitriles

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE:To provide black particles having narrow particle size distribution, and uniform shape and size, and usable as pigment, absorbent, filler, electrical conductive material, and especially material for medical diagnostic, by treating particles of acrylonitrile polymer at a specific temperature. CONSTITUTION:The objective black particles can be produced by oxidizing particles of an acrylonitrile polymer at 150-300 deg.C, and heating the product at >=450 deg.C. The acrylonitrile polymer may be an acrylonitrile copolymer having an acrylonitrile content of >=85mol%, preferably >=90mol%, as wel as the homopolymer of acrylonitrile. The above polymer particles may be produced by emulsion polymerization or suspension polymerization, however, particles produced by precipitation polymerization (preferably precipitation polymerization from ethyl propionate or n-butyl acetate solution) is preferable. The particle diameter is preferably 0.05-10mum.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は顔料、吸着剤、フィラー、トナー、電気伝導体
、特に医学診断材料などに使用可能な黒色粒子に関する
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to black particles that can be used as pigments, adsorbents, fillers, toners, electrical conductors, and in particular medical diagnostic materials.

〔従来の技術〕[Conventional technology]

黒色粒子として代表的なものにカーボンブランクがある
Carbon blank is a typical example of black particles.

カーボンブラックは炭化水素の熱分解と不完全燃焼によ
って製造され、顔料、フィラー、あるいはトナーなどに
使用されている。
Carbon black is produced by pyrolysis and incomplete combustion of hydrocarbons and is used in pigments, fillers, and toners.

しかしながらカーボンブラックは非常に微細(平均0.
02μ)で形状も不均一であり、このままでは医学診断
材料などには使用不可能である。
However, carbon black is very fine (average 0.
02μ) and non-uniform in shape, it cannot be used as a medical diagnostic material as it is.

医学診断材料とは、例えば免疫学的凝集試薬の担体であ
る。
The medical diagnostic material is, for example, a carrier for an immunological agglutination reagent.

さらに具体的には抗原f抗体反応により、体液中の抗原
または抗体を検出しようとする際に、予め抗原または抗
体を固定化した担体を抗体または抗原を含む体液と混合
することにより固定化された抗原と体液中の抗体、ある
いは固定化された抗体と体液中の抗原が抗原f抗体反応
により、抗体同志を架橋するように結合して担体の凝集
を起こす。
More specifically, when attempting to detect an antigen or antibody in a body fluid by an antigen-antibody reaction, a carrier on which an antigen or antibody has been immobilized in advance is mixed with a body fluid containing the antibody or antigen. The antigen and the antibody in the body fluid, or the immobilized antibody and the antigen in the body fluid, bind to each other so as to crosslink the antibodies, causing aggregation of the carrier.

この凝集の有無または程度を検定することにより抗原ま
たは抗体を定性的あるいは定量的に検出することができ
る。
The antigen or antibody can be detected qualitatively or quantitatively by testing the presence or extent of this agglutination.

この際、抗体が黒色であるということは、肉眼および顕
微鏡観察による検定を容易にすることができるという利
点がある。さらに担体の形状、大きさが一定であるとい
うことも検定を容易にする大きな要素の一つであるが、
カーボンブランクは、非常に微細で形状も不均一であり
上述の様な診断用材料には不向きである。
In this case, the fact that the antibody is black has the advantage that it can be easily assayed by visual and microscopic observation. Furthermore, the fact that the shape and size of the carrier are constant is one of the major factors that facilitates the assay.
Carbon blanks are extremely fine and non-uniform in shape, making them unsuitable as diagnostic materials as described above.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

本発明は、医学診断材料にも使用可能な均一な黒色粒子
を提供することを目的とする。
The present invention aims to provide uniform black particles that can also be used in medical diagnostic materials.

〔問題を解決するための手段〕[Means to solve the problem]

すなわち本発明は、アクリロニトリル系重合体粒子を1
50〜300℃の温度で酸化処理し、次いで450℃以
上の温度で加熱処理してなる黒色粒子である。
That is, in the present invention, 1 acrylonitrile polymer particle is
These black particles are obtained by oxidation treatment at a temperature of 50 to 300°C and then heat treatment at a temperature of 450°C or higher.

本発明のアクリロニトリル系重合体粒子は、乳化重合、
懸濁重合または沈澱重合等どの様な方法で調製されたも
のでもかまわないが、沈澱重合がより好ましい。
The acrylonitrile polymer particles of the present invention can be obtained by emulsion polymerization,
It may be prepared by any method such as suspension polymerization or precipitation polymerization, but precipitation polymerization is more preferable.

すなわち、乳化重合により調製されたアクリロニトリル
重合体粒子は均一であるが、一般に微細になりやすく、
また重合度および重合率を支配する条件として触媒、乳
化剤の種類および濃度、水の量および水溶液のpH1添
加剤の種類およびその濃度、攪拌速度等影響する要因が
多く条件の再現が容易ではない。
That is, acrylonitrile polymer particles prepared by emulsion polymerization are uniform, but generally tend to be fine.
In addition, there are many factors that influence the degree of polymerization and polymerization rate, such as the type and concentration of the catalyst and emulsifier, the amount of water, the type and concentration of the pH1 additive in the aqueous solution, and the stirring speed, and it is not easy to reproduce the conditions.

沈澱重合は、単量体は溶解するが生成重合体は沈澱析出
するような溶媒中で重合させる方法である。
Precipitation polymerization is a method of polymerizing in a solvent in which the monomer is dissolved but the resulting polymer is precipitated.

沈澱重合によるアクリロニトリル系重合体粒子の調製は
特開昭56−156213に記載された方法に従って実
施することができる。
Preparation of acrylonitrile polymer particles by precipitation polymerization can be carried out according to the method described in JP-A-56-156213.

この沈澱重合は重合条件のコントロールが容よって水あ
るいは有機溶媒、好ましくはプロピオン酸エチルまたは
酢酸−n−ブチル溶液からの沈澱重合により調製したア
クリロニトリル重合体粒子を焼成して得られた黒色粒子
は医学診断材料等に適している。
In this precipitation polymerization, it is easy to control the polymerization conditions, and the black particles obtained by calcining acrylonitrile polymer particles prepared by precipitation polymerization from water or an organic solvent, preferably ethyl propionate or n-butyl acetate solution are suitable for medical use. Suitable for diagnostic materials, etc.

本発明のアクリロニトリル系重合体としては、好ましく
は90モル%以上であるアクリ、ロニトリル共重合体で
も良い。
The acrylonitrile-based polymer of the present invention may be an acryl-lonitrile copolymer having a content of preferably 90 mol % or more.

その共重合成分としては、アリルアルコール、メタアリ
ルアルコール、オキシプロピオンアクリロニトリル、ア
クリル酸、メタクリル酸、イタコン酸、クロトン酸、メ
タアクリロニトリル、α−メチレンゲルタロニトリル、
イソプロペニルアセテート、アクリルアミド、N−メチ
ロールアクリルアミド、β−ヒドロキシエチルメタアク
リレート、ジメチルアミノエチルメタアクリレート、β
−ヒドロキシエチルアクリロニトリル、ビニルピリジン
、ビニルピロリドン、アクリル酸メチル、メタアクリル
酸メチル、酢酸ビニル、アリルクロライド、メタアリル
スルホン酸ソーダ、p−スチレンスルホン酸カリ等の周
知のエチレン系不飽和化合物を挙げることができる。
The copolymerization components include allyl alcohol, methalyl alcohol, oxypropion acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, crotonic acid, methacrylonitrile, α-methylene geltalonitrile,
Isopropenyl acetate, acrylamide, N-methylolacrylamide, β-hydroxyethyl methacrylate, dimethylaminoethyl methacrylate, β
- To mention well-known ethylenically unsaturated compounds such as hydroxyethyl acrylonitrile, vinylpyridine, vinylpyrrolidone, methyl acrylate, methyl methacrylate, vinyl acetate, allyl chloride, sodium metaallylsulfonate, and potassium p-styrenesulfonate. I can do it.

本発明の粒子は、粒子径が好ましくは0.05〜10μ
mさらに好ましくは0.1〜4μ川であり、しかも単分
散性であるものがよい。
The particles of the present invention preferably have a particle size of 0.05 to 10μ.
More preferably, it is 0.1 to 4μ, and is monodisperse.

本発明の黒色粒子は、アクリロニトリル系重合体粒子を
次の様に焼成することにより得られる。
The black particles of the present invention are obtained by firing acrylonitrile polymer particles as follows.

焼成はまず前処理として温度調節可能な加熱装置中で気
体状酸素または気体状硫黄を含む雰囲気下、好ましくは
空気の存在下150℃〜300℃、好ましくは200℃
〜250℃の温度で数時間、好ましくは4〜6時間加熱
して酸化処理を行う。
Firing is first performed as a pretreatment in a temperature-adjustable heating device in an atmosphere containing gaseous oxygen or gaseous sulfur, preferably in the presence of air at 150°C to 300°C, preferably at 200°C.
The oxidation treatment is carried out by heating at a temperature of ~250°C for several hours, preferably 4 to 6 hours.

次いで気体状酸素、または気体状硫黄の非存在下好まし
くは窒素、アルゴン、ヘリウム等の不活性ガス気流下に
450℃以上の温度で数分間から、数時間加熱処理する
Next, heat treatment is performed at a temperature of 450° C. or higher for several minutes to several hours in the absence of gaseous oxygen or gaseous sulfur, preferably under a stream of an inert gas such as nitrogen, argon, or helium.

焼成温度は黒色粒子の用途により変えるのが望ましい。It is desirable to change the firing temperature depending on the use of the black particles.

例えば吸着剤あるいは電気伝導体として使用する場合は
1000℃以上の温度で焼成するのが好ましい。
For example, when used as an adsorbent or an electrical conductor, it is preferable to sinter at a temperature of 1000° C. or higher.

また焼成前にアクリロニトリル重合体粒子をシリコーン
で処理することにより黒色粒子の単分散性を改良するこ
とができる。
Furthermore, the monodispersity of the black particles can be improved by treating the acrylonitrile polymer particles with silicone before firing.

本発明の黒色粒子は医学診断材料として最適である。例
えば前述の様な免疫学的凝集試薬の担体である。
The black particles of the present invention are most suitable as medical diagnostic materials. For example, it is a carrier for an immunological agglutination reagent as described above.

この場合、予め抗原または抗体を本発明の黒色粒子に固
定化し、次にこの粒子を抗体または抗原を含む測定試料
液と混合することにより、凝集反応を測定する。
In this case, the agglutination reaction is measured by immobilizing the antigen or antibody on the black particles of the present invention in advance, and then mixing the particles with a measurement sample solution containing the antibody or antigen.

黒色粒子に抗原または抗体を固定化するには物理的吸着
法が好ましい。
Physical adsorption is preferred for immobilizing antigens or antibodies on black particles.

抗原、抗体としては、具体的には例えば、連鎖球菌、ブ
ドウ球菌、ジフテリア菌、サルモネラ菌、赤痢菌などの
細菌およびその構成成分に対する抗体;梅毒トレポネー
マなどのスピロヘータおよびその構成成分に対する抗体
;マイコプラズマおよびその構成成分に対する抗体;マ
ラリア原虫などの原虫類およびその構成成分に対する抗
体;リケソチャアおよびその構成成分に対する抗体;イ
ンフルエンザ、アデノウィルス、ポリオーマ、麻疹、風
疹、肝炎、おたふくかぜなどのウィルスおよびその構成
成分ならびにそれらに対する抗体;多i1M、ヒトアル
ブミン、卵白アルブミンなどの異種抗原ならびにそれら
に対する抗体;インシュリン、サイロイドホルモン、絨
毛性ゴナドトロピンなどのホルモン;リボヌクレアーゼ
、タレアチンホスホキナーゼ、アスパラギナーゼなどの
酵素;腎臓細胞膜、肝臓細胞膜、α−フェトプロティン
、CEAなどの器管固有の抗原またはりセプター;コラ
ーゲン、アミロイドなどの結合組織成分;赤血球、血小
板などの血球抗原、またはりセプター;フィブリン、プ
ラズミノーゲンなどの血漿タンパク賞与リューマチ因子
やC反応性タンパク質などの病理グロブリン;免疫複合
体;細胞膜などに対する自己抗体などがある。
Specific examples of antigens and antibodies include antibodies against bacteria such as Streptococcus, Staphylococcus, Diphtheria, Salmonella and Shigella, and their constituent components; antibodies against spirochetes such as Treponema pallidum and their constituents; mycoplasma and their constituents; Antibodies against constituent components; Antibodies against protozoa such as malaria parasites and their constituent constituents; Antibodies against Lykesocharia and their constituent constituents; Viruses such as influenza, adenovirus, polyoma, measles, rubella, hepatitis, mumps and their constituent constituents and antibodies against them. ; Heterologous antigens such as polyi1M, human albumin, and ovalbumin and antibodies against them; Hormones such as insulin, thyroid hormone, and chorionic gonadotropin; Enzymes such as ribonuclease, taleatin phosphokinase, and asparaginase; Kidney cell membrane, liver cell membrane, α - Organ-specific antigens and receptors such as fetoprotein and CEA; connective tissue components such as collagen and amyloid; blood cell antigens and receptors such as red blood cells and platelets; plasma proteins such as fibrin and plasminogen; rheumatoid factors and These include pathological globulins such as C-reactive protein; immune complexes; and autoantibodies against cell membranes.

また、医学診断材料としてさらに例をあげればマーカー
である。例えば細胞標識である。
Another example of medical diagnostic materials is markers. For example, cell labels.

血球のうちリンパ球にはB細胞とT細胞があり、B細胞
はその表面に免疫グロブリンのFc部分に対するレセプ
ターや補体に対するレセプターをもっていてT細胞には
それらがない。
Among blood cells, lymphocytes include B cells and T cells. B cells have receptors for the Fc portion of immunoglobulins and receptors for complement on their surfaces, while T cells do not have them.

そこでマーカーとする粒子に免疫グロブリンまたは補体
を感作して、リンパ球と混合することによりマーカー粒
子がB細胞のレセプターと結合してロゼツトを形成する
Therefore, the marker particles are sensitized with immunoglobulin or complement and mixed with lymphocytes, whereby the marker particles bind to B cell receptors and form rosettes.

このような細胞の標識を診断に役立てることができる。Labeling of such cells can be useful for diagnosis.

本発明の黒色粒子は、免疫学的凝集法、細胞標識以外の
診断材料としてももちろん使用可能である。
The black particles of the present invention can of course be used as diagnostic materials other than immunological agglutination methods and cell labeling.

さらに1.医学診断材料はもとより顔料、吸着剤・フィ
ラー、トナー、電気伝導体tなどにも使用可能である。
Furthermore 1. It can be used not only for medical diagnostic materials but also for pigments, adsorbents/fillers, toners, electrical conductors, etc.

またフィラーとしての特殊用途として、耐熱性無機材料
中に充填して成型後、該黒色粒子を酸化して炭酸ガスに
変換することにより多孔性無機成型品とすることもでき
る。
In addition, as a special use as a filler, a porous inorganic molded product can be obtained by filling the black particles into a heat-resistant inorganic material and molding the black particles, and then oxidizing the black particles and converting them into carbon dioxide gas.

〔発明の効果〕〔Effect of the invention〕

本発明の黒色粒子は、粒度分布が狭く、形状も一定な均
一粒子であるため、医学診断材料をはじめとして多方面
に応用可能な粒子である。
Since the black particles of the present invention are uniform particles with a narrow particle size distribution and a constant shape, they can be applied to many fields including medical diagnostic materials.

以下実施例を挙げて本発明をさらに具体的に説明する。EXAMPLES The present invention will be explained in more detail with reference to Examples below.

実施例1゜ 試験管中でアクリロニトリル6g、2.2′−アゾビス
−(2,4−ジメチルバレロニトリル) 20mg、お
よびプロピオン酸エチル20g、をよく混合して窒素置
換抜栓をして45℃の恒湿槽中に16時間静置した。試
験管内容物をアセトン100m1に注ぎ遠沈によりアセ
トン洗浄後アクリロニトリル重合体粒子をテトラヒドロ
フラン50gに分散した。
Example 1 In a test tube, 6 g of acrylonitrile, 20 mg of 2,2'-azobis-(2,4-dimethylvaleronitrile), and 20 g of ethyl propionate were thoroughly mixed, the cap was replaced with nitrogen, and the cap was kept at 45°C. It was left standing in a wet tank for 16 hours. The contents of the test tube were poured into 100 ml of acetone, and after washing with acetone by centrifugation, the acrylonitrile polymer particles were dispersed in 50 g of tetrahydrofuran.

“トーレシリコーン”5H−200オイルヲ0.5g加
え、攪拌混合して遠沈後上澄を除き沈渣を減圧下に乾燥
した。
0.5 g of "Toray Silicone" 5H-200 oil was added, stirred and mixed, and after centrifugation, the supernatant was removed and the precipitate was dried under reduced pressure.

シリコーン処理アクリロニトリル重合体粒子をアルミ容
器に採り、空気雰囲気下200℃で2時間、次いで24
0℃で4時間加熱して酸化処理した。
The silicone-treated acrylonitrile polymer particles were placed in an aluminum container and heated at 200°C for 2 hours in an air atmosphere, then for 24 hours.
Oxidation treatment was performed by heating at 0° C. for 4 hours.

酸化処理アクリロニトリル重合体粒子をアルミ容器上で
窒素気流下500℃、800“Cおよび1,100℃の
それぞれの温度に加熱焼成した。
The oxidized acrylonitrile polymer particles were fired in an aluminum container under a nitrogen stream at temperatures of 500°C, 800"C, and 1,100°C, respectively.

各焼成アクリロニトリル重合体粒子の元素分析結果を表
′1に示す。
Table 1 shows the results of elemental analysis of each fired acrylonitrile polymer particle.

表1 500℃以上で焼成したものは黒色であり、顕微鏡で観
察したところ、粒子相互の融着はほとんど認められなか
った。
Table 1 Those fired at 500° C. or higher were black in color, and when observed under a microscope, almost no fusion between particles was observed.

走査電子顕微鏡写真によれば、粒子形はほぼ球状であり
、粒子径は0.5〜0.6μmでほぼ均一であった。
According to a scanning electron micrograph, the particle shape was approximately spherical, and the particle diameter was approximately uniform at 0.5 to 0.6 μm.

実施例2 実施例1において800℃で焼成して得た黒色粒子の5
%分散水0.5tnl!に梅毒血清診断用ガラス抜法抗
原(住友化学工業)1m、++を加えて37℃ブミン1
χを含有する0、01Mリン酸緩衝生理食塩水溶液(p
H=7.0)に2.5χ となるように分散した。
Example 2 5 of the black particles obtained by firing at 800°C in Example 1
% dispersion water 0.5tnl! Add 1 m of glass extraction antigen for syphilis serum diagnosis (Sumitomo Chemical Co., Ltd.) and ++ to 37°C Bumin 1.
A 0.01M phosphate buffered saline solution containing χ (p
H = 7.0) and was distributed to be 2.5χ.

上記分散液と梅毒抗体陽性血清をスライドガラス上で混
合したところ黒色粒子の凝集が認められた。
When the above dispersion and syphilis antibody-positive serum were mixed on a glass slide, aggregation of black particles was observed.

Claims (1)

【特許請求の範囲】[Claims] (1)アクリロニトリル系重合体粒子を150〜300
℃の温度で酸化処理し、次いで450℃以上の温度で加
熱処理してなる黒色粒子。
(1) 150 to 300 acrylonitrile polymer particles
Black particles obtained by oxidation treatment at a temperature of 450°C or higher and then heat treatment at a temperature of 450°C or higher.
JP59148096A 1984-07-17 1984-07-17 Black particle Pending JPS6126505A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59148096A JPS6126505A (en) 1984-07-17 1984-07-17 Black particle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59148096A JPS6126505A (en) 1984-07-17 1984-07-17 Black particle

Publications (1)

Publication Number Publication Date
JPS6126505A true JPS6126505A (en) 1986-02-05

Family

ID=15445151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59148096A Pending JPS6126505A (en) 1984-07-17 1984-07-17 Black particle

Country Status (1)

Country Link
JP (1) JPS6126505A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2326362B (en) * 1997-06-10 1999-09-08 Kvaerner Tech & Res Ltd Metal rolling with multiple casters
US6143835A (en) * 1998-04-03 2000-11-07 Solutia Inc. Polyacrylonitrile polymer treatment
US6277933B1 (en) 1998-04-03 2001-08-21 Solutia Inc. Polyacrylonitrile particles by surfmer polymerization and sodium removal by chemical exchange
EP1564227A1 (en) * 1999-04-09 2005-08-17 Dynal Biotech ASA Process for the preparation of monodisperse polymer particles
WO2005097674A1 (en) * 2004-03-30 2005-10-20 Kureha Corporation Process for producing spherical carbon material
CN1311005C (en) * 1999-04-09 2007-04-18 迪纳尔生物技术公司 Process for the preparation of monodisperse polymer particles
WO2011078145A1 (en) 2009-12-24 2011-06-30 東レ株式会社 Carbon microparticle and process for production thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4948821A (en) * 1972-07-06 1974-05-11
JPS50148292A (en) * 1974-05-22 1975-11-27
JPS51132193A (en) * 1975-05-14 1976-11-17 Toho Rayon Co Ltd Process for production of activated charcoal
JPS522696A (en) * 1975-06-24 1977-01-10 Akira Nakaima Automatic transferring apparatus of bags
JPS525696A (en) * 1975-07-01 1977-01-17 Sumitomo Chem Co Ltd Production of carbonaceous materials
JPS5350088A (en) * 1976-10-19 1978-05-08 Sumitomo Chem Co Ltd Production of spherical activated carbon
JPS56156213A (en) * 1980-05-06 1981-12-02 Toray Ind Inc Preparation of immunologically active fine particle

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4948821A (en) * 1972-07-06 1974-05-11
JPS50148292A (en) * 1974-05-22 1975-11-27
JPS51132193A (en) * 1975-05-14 1976-11-17 Toho Rayon Co Ltd Process for production of activated charcoal
JPS522696A (en) * 1975-06-24 1977-01-10 Akira Nakaima Automatic transferring apparatus of bags
JPS525696A (en) * 1975-07-01 1977-01-17 Sumitomo Chem Co Ltd Production of carbonaceous materials
JPS5350088A (en) * 1976-10-19 1978-05-08 Sumitomo Chem Co Ltd Production of spherical activated carbon
JPS56156213A (en) * 1980-05-06 1981-12-02 Toray Ind Inc Preparation of immunologically active fine particle

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2326362B (en) * 1997-06-10 1999-09-08 Kvaerner Tech & Res Ltd Metal rolling with multiple casters
US6143835A (en) * 1998-04-03 2000-11-07 Solutia Inc. Polyacrylonitrile polymer treatment
US6277933B1 (en) 1998-04-03 2001-08-21 Solutia Inc. Polyacrylonitrile particles by surfmer polymerization and sodium removal by chemical exchange
EP1564227A1 (en) * 1999-04-09 2005-08-17 Dynal Biotech ASA Process for the preparation of monodisperse polymer particles
CN1311005C (en) * 1999-04-09 2007-04-18 迪纳尔生物技术公司 Process for the preparation of monodisperse polymer particles
AU2004222716B2 (en) * 1999-04-09 2007-07-05 Invitrogen Dynal As Process for the preparation of monodisperse polymer particles
US8658733B2 (en) 1999-04-09 2014-02-25 Life Technologies As Process for the preparation of monodisperse polymer particles
US9309368B2 (en) 1999-04-09 2016-04-12 Life Technologies As Process for the preparation of monodisperse polymer particles
WO2005097674A1 (en) * 2004-03-30 2005-10-20 Kureha Corporation Process for producing spherical carbon material
US7651817B2 (en) 2004-03-30 2010-01-26 Kureha Corporation Process for producing spherical carbon material
JP4836781B2 (en) * 2004-03-30 2011-12-14 株式会社クレハ Method for producing spherical carbon material
WO2011078145A1 (en) 2009-12-24 2011-06-30 東レ株式会社 Carbon microparticle and process for production thereof

Similar Documents

Publication Publication Date Title
JPH087214B2 (en) Indicator reagent and assay method using the same
JPH0717697B2 (en) Bioactive reagents made from carboxy-containing polymers, analytical elements and methods of use
JP6080164B2 (en) Fluorescently labeled particles
WO2015050150A1 (en) Method for detecting target substance
JPS6126505A (en) Black particle
KR20050113231A (en) Reduction of the hook effect in assay devices
JP7091128B2 (en) Particles and their manufacturing methods
JP4884981B2 (en) Reduction of time required for blood bank diagnostic tests
JPH0527064B2 (en)
JPH102900A (en) Method for detecting analyte in sample liquid, reagent kit and reaction vessel
JPS59116548A (en) Diagnostic chemical containing hydrophilic latex particle
US5656506A (en) Dry detection reagent containing acrylamide/styrene copolymer particles immobilizing an immunologically active substance
JP2008089415A (en) Examination reagent and examination method
JP2007211076A (en) Organic polymer particle and method for producing the same, and probe-binding particle
JPH073426B2 (en) Carrier of diagnostic agglutination reagent
JPH0810223B2 (en) LATEX FOR DIAGNOSTIC AGENT, PROCESS FOR PRODUCING THE SAME, AND DIAGNOSTIC AGENT USING THE LATEX
JP4897581B2 (en) Method for producing hydrophilized magnetic body-encapsulated particles, hydrophilized magnetic body-encapsulated particles, and immunoassay particles
JP3657015B2 (en) Reagent kit for immune reaction measurement
JPS6116942B2 (en)
JP5048423B2 (en) Agglomeration inspection fine particles
JPH05180842A (en) Measurement of material in vivo by antigen/antibody reaction
JPH04323560A (en) Magnetic particle labelling material for use in laser magnetic immunity measurement and adjusting method for subject
JPS59182804A (en) Reactive fine particle and production thereof
JPH0743383B2 (en) Carrier latex for diagnostic reagents
JPS6116943B2 (en)